Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TRK-851

RK-851 is a highly selective and orally active δ-opioid receptor antagonist, with a negative logarithm of the antagonist concentration (pA2) of 8.84. TRK-851 exhibits the selectivity for the δ receptor of more than 100 times higher than that for the μ or κ receptors. TRK-851 exhibits a potent antitussive effect in a rat model of capsaicin-induced cough. TRK-851 can be used for research on antitussive effects[1].

Product Specifications

CAS Number

[189015-24-5]

UNSPSC

12352005

Target

Opioid Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Smiles

O[C@]12[C@]34[C@](OC5=C(O)C=CC(C[C@@]2([H])N(CC4)CC6CC6)=C53)([H])C7=C(C8=CC(F)=CC9=C8N7CCC9)C1

Molecular Formula

C29H29FN2O3

Molecular Weight

472.55

References & Citations

[1]Sakami S, et al. Design and synthesis of a metabolically stable and potent antitussive agent, a novel delta opioid receptor antagonist, TRK-851. Bioorg Med Chem. 2008 Sep 1;16 (17) :7956-67.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

Phase 1

Isoform

δ Opioid Receptor/DOR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SEPARASE antibody (Ser801)
70R-31053 100 ug

SEPARASE antibody (Ser801)

Ask
View Details
DS15000+2000
M1242 5x 50 μg

DS15000+2000

Ask
View Details
GPR120 Antibody
F45258-0.4ML 0.4 mL

GPR120 Antibody

Ask
View Details
Recombinant Carnitine Acetyltransferase (CRAT)
SIPC761Hu01-01 10 µg

Recombinant Carnitine Acetyltransferase (CRAT)

Ask
View Details
Recombinant Carnitine Acetyltransferase (CRAT)
SIPC761Hu01-02 50 µg

Recombinant Carnitine Acetyltransferase (CRAT)

Ask
View Details
Recombinant Carnitine Acetyltransferase (CRAT)
SIPC761Hu01-03 200 µg

Recombinant Carnitine Acetyltransferase (CRAT)

Ask
View Details